Значения термина carcinoma bladder на английском

In past years, laboratory diagnosis and surveillance of urinary bladder cancer have improved significantly.

In this study, we aimed to investigate the physiological role of GPR137 in urinary bladder cancer.

Lung cancer is third, followed by colon cancer, women with cancer of the uterus, and urinary bladder cancer.

Knowing the HER-2 status would be helpful in formulating a rational treatment strategy for patients with urinary bladder cancer.

Increases in incidence of non-Hodgkin's lymphoma and of cervical, esophageal, and urinary bladder cancer have been observed for workers exposed to Perc.

Conclusions: Fibulin-5 is down-regulated in urothelial carcinoma of bladder and acts as a tumor suppressor gene by inhibiting proliferation and invasion of bladder cancer cells.

Purpose: The expression of fibulin-5 was investigated in urothelial carcinomas of bladder and in normal bladder samples.

Advanced urothelial carcinoma of the bladder is associated with a high metastatic potential.

Transitional cell carcinoma of the bladder is a chemo-sensitive neoplasm.

The patient was a 64-year-old woman being followed up for transitional cell carcinoma of the bladder.

A conservative primary approach seems justifiable in the management of double carcinoma of the bladder and prostate.

Background: Recurrence of transitional cell carcinoma of the bladder cannot be predicted accurately by traditional criteria alone.

Studies on HER-2 expression in bladder carcinoma have shown heterogeneous results.

Brachytherapy has a key role to play in the treatment of bladder carcinoma.

Pathologic examination showed similar histologic and immunohistochemical characteristics as the primary bladder carcinoma.

Purpose: We report the presentation of brain metastases from bladder carcinoma.

Results: Brain metastases from bladder carcinoma were commonly accompanied by uncontrolled systemic metastases.

It was around that time, too, that Daldry's father died of cancer of the bladder.

In this article, we review available evidence on the treatment of patients with nonurothelial cancer of the bladder.

Discovery of blood in the urine took him to Manhattan's Memorial Hospital with suspected cancer of the bladder.

Kray, 66, is terminally ill with cancer of the bladder and has a life expectancy of only a few weeks.

This reduction was especially marked for cancer in the respiratory system, cancer of the prostate and cancer of the bladder.

Purpose: The standard treatment for patients with muscle-invasive carcinoma of the urinary bladder is radical cystectomy.

We treated in total 795 patients with primary transitional cell carcinoma of the urinary bladder between April, 1964 and December, 1988.

Conclusion: Over-expression of HER-2 was frequent in carcinomas of the urinary bladder.

Two hundred eighty-five primary human carcinomas of the urinary bladder were examined for allelic loss on chromosome 14q.

The relationship between interphase cytogenetics and tumor grade, stage, and proliferative activity was investigated in 27 transitional cell carcinomas of the urinary bladder.

However, the mechanisms responsible for angiogenesis in urinary bladder carcinoma patients are not well defined.

Computed tomography showed diffuse, circumferential, irregular, and lobulated thickening of the bladder wall suggestive of urinary bladder carcinoma.

The AR is also involved in the development and progression of urinary bladder carcinoma, which is the most common type of carcinoma.

It may be suggested that the urinary bladder carcinoma induced by CPM is related not only total dose of CPM but also the other factors.

A case of urinary bladder carcinoma in a patient with malignant lymphoma (ML) involving the thyroid gland, gastrointestinal tract and the gallbladder is reported.